Find information on thousands of medical conditions and prescription drugs.

Cholesterol pneumonia

Cholesterol pneumonia is pneumonia due to cholesterol. Symptoms include tachypnea, cough and cyanosis.

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Laboratory abnormalities in patients with bacterial pneumonia
From CHEST, 3/1/97 by Ramkumar T. Sankaran

Pneumonia is the most common life-threatening infectious disease.[1] Pleuropulmonary infection remains the fifth most common cause of mortality in the United States, accounting for an estimated 55,000 deaths annually.[2] Pneumonia is associated with significant morbidity and prolonged, costly hospitalization, particularly when nosocomial in origin.[3]

Hypophosphatemia is found in approximately 2 to 3% of patients admitted to hospital with medical illness.[4-6] Commonly reported etiologies of hypophosphatemia include alcohol withdrawal/alcoholism, diabetic ketoacidosis, nutritional recovery, alkalotic states, accelerated erythropoiesis, and Gram-negative sepsis.[7-13] The triad of hypophosphatemia, hypokalemia, and hypomagnesemia has been described in patients in intensive therapy setting, postoperative patients, those with sepsis being treated with aminoglycosides, and oncology patients receiving chemotherapy.[14] Many drugs are known to induce hypophosphatemia, the most common among these being methylprednisolone, epinephrine, albuterol, terbutaline, theophylline, and diethylstilbestrol.[15] Selected cases of atypical pneumonia have been shown to be associated with hypophosphatemia.[16] The mechanism may be through the associated respiratory alkalosis which is known to mediate an intracellular shift of phosphate.[17-19]

Hypophosphatemia, in addition to its association with conditions listed above, is known to play a role in the impaired chemotaxis, phagocytosis, and bactericidal activity of macrophages.[20] There are scanty data on the association of other laboratory abnormalities with the morbidity and mortality in patients with bacterial pneumonia.

MATERIALS AND METHODS

We reviewed the medical records of 353 consecutive patients admitted to Long Island Jewish Medical Center, New Hyde Park, NY, from January 1, 1993 through December 31, 1993, who had bacterial pneumonia as their discharge diagnosis. Of these, 302 patients had documented evidence of bacterial pneumonia, based on chest radiographic evidence of infiltrate with or without positive sputum culture. All of them had at least one full blood chemistry panel drawn at the time of hospital admission. Fifty-one patients were excluded from the study based on one of the following criteria: evidence of respiratory alkalosis on arterial blood gas analysis (pH [is greater than or equal to] 7.5), chronic alcoholism or alcohol withdrawal, antacid therapy, evidence of disorders like congestive heart failure mimicking pneumonia, or Gram-negative sepsis as all these conditions have been shown to independently cause hypophosphatemia.

Of these 302 patients who satisfied the criteria, the following information was recorded: age, sex, time of occurrence of bacterial pneumonia (on admission or acquired later during hospitalization), number of days of hospital stay, disposition (survival or death), and laboratory tests, including sodium, potassium, chloride, bicarbonate, urea nitrogen, creatinine, glucose, calcium, phosphorus, total protein, albumin, cholesterol, creatine phosphokinase, alanine transferees, aspartate transferase, and alkaline phosphatase on admission or before the onset of pneumonia if this developed in the hospital. Hypophosphatemia was defined as a serum phosphorus level [is less than or equal to] 2.4 mg/dL. The patients were divided into two groups based on the normal or low serum phosphorus level and clinical and laboratory data were compared between the two groups. To compare the admission electrolyte profile of patients treated for bacterial pneumonia with those of the patients admitted for the treatment of all medical conditions, we also reviewed 300 randomly selected hospital admissions (for conditions other than pneumonia) and recorded the laboratory data as above.

Both univariate and multivariate analyses were employed. Student's two-tailed t test was used to compare individual variables between groups. Proportions were compared using [Chi-Square] test with continuity correction or Fisher's Exact Test when applicable. To identify the best set of variables that predicted the incidence of pneumonia, we carried out stepwise multiple logistic regression analysis. The results were expressed as mean [+ or -] SEM. A p value [is less than] 0.05 was considered significant.

RESULTS

The total medical admissions to the Long Island Jewish Medical Center over a 3-month period included 7,994 patients. Of these, 640 had documented hypophosphatemia at admission or some time during their hospital stay (8%). In the control group of 300 patients, 31 had documented hypophosphatemia (10.3%). Among 302 patients with a discharge diagnosis of bacterial pneumonia, 135 patients had documented hypophosphatemia (44.7%) (p [is less than] 0.0001 compared to all hospitalized patients and control group). The sex distribution of the patients among the groups was not significantly different among the groups (control group, female 56.7% vs pneumonia group, female 53.9%). The patients who suffered from hypophosphatemia and pneumonia were significantly older than the control group of medical admissions but not different from the normophosphatemic patients admitted with bacterial pneumonia (hypophosphatemia, 67.5 [+ or -] 1.9 years vs control group, 60.7 [+ or -] 1.1 years, p [is less than] 0.001; normophosphatemia, 63.4 [+ or -] 1.5 years, p=not significant).

Patients with bacterial pneumonia did not show any difference in sodium, potassium, chloride, glucose, urea nitrogen, creatinine, bilirubin, alkaline phosphatase, creatine phosphokinase, or aspartate transaminase vs the group of patients admitted for conditions other that pneumonia. In contrast, those admitted for bacterial pneumonia demonstrated significantly lower levels of cholesterol, albumin, calcium, phosphorus, and alanine transaminase (Table 1).

Table 1--Biochemical Profile of Patients With Pneumonia and Other Medical Conditions(*)

(*) Hospital admission blood chemistry results of 302 consecutive patients with the diagnosis of bacterial pneumonia (pneumonia) were compared with the admission blood profile of 300 randomly selected patients admitted for all medical problems (control) other than pneumonia. Biochemical variables were compared using the Student's unpaired two-tailed t test. Results are expressed as mean [+ or -] SEM. ALT=alanine transaminase.

Table 2 summarizes the differences in the biochemical profile of hypophosphatemic subjects with bacterial pneumonia compared to their normophosphatemic counterparts. Hypophosphatemic patients revealed lower levels of potassium, calcium, and albumin compared to their normophosphatemic counterparts. However, hypophosphatemic patients had higher glucose levels. The serum levels of sodium, chloride, urea nitrogen, bicarbonate, creatinine, uric acid, bilirubin, alkaline phosphatase, cholesterol, and aspartate transaminase were not significantly different between the two groups. Moreover, hypophosphatemic patients with pneumonia stayed significantly longer (Fig 1) in the hospital (hypophosphatemia, 24.6 [+ or -] 2.1 days vs normophosphatemia, 14.1 [+ or -] 1.0; p [is less than] 0.0001). As shown in Figure 2, hypophosphatemic subjects had a higher mortality rate (p [is less than] 0.001) than their normophosphatemic counterparts.

[Figure 1, 2 ILLUSTRATION OMITTED]

Table 2--Biochemical Profile of Hypophosphatemic and Normophosphatemic Subjects With Pneumonia(*)

(*) Biochemical data from 302 consecutive patients who were admitted to the hospital for bacterial pneumonia were analyzed. Of these, 135 developed hypophosphatemia either on admission or during their hospital stay. One hundred sixty-seven patients were normophosphatemic on admission and throughout their stay in hospital. The biochemical profiles of the two groups of patients were compared using the Student's unpaired two-tailed t test. The results were expressed as mean [+ or -] SEM. CPK=creatine phosphokinase.

The results of the stepwise multiple logistic regression analysis to identify the best predictors of pneumonia are summarized in Table 3. Patients with pneumonia had higher levels of potassium, bicarbonate, and total protein and lower serum levels of phosphorus, calcium, and albumin in comparison with the control group.

Table 3--Laboratory Data in Patients With Pneumonia(*)

(*) Hospital admission chemistry results of the patients with pneumonia were compared to those without pneumonia to identify the variables that best predicted the onset of pneumonia using the stepwise logistic regression analysis. AST=aspartate transaminase.

Among the patients who experienced hypophosphatemia, 88 patients were admitted with low phosphorus levels and 47 patients had normal phosphorus levels during admission and subsequently developed hypophosphatemia in the hospital. Twenty-two of the 88 patients (25%) with admission hypophosphatemia and 21 of the 47 (44.7%) with in-hospital hypophosphatemia died. As represented in Figure 3, the mortality in patients with in-hospital hypophosphatemia was significantly increased in contrast to both those with admission hypophosphatemia as well as those with normophosphatemia (in-hospital hypophosphatemia, 21 of 47 patients died vs admission hypophosphatemia, 22 of 88 patients, p=0.0321; and vs normophosphatemic patients, 22 of 167 patients; p [is less than] 0.0001). The difference in mortality rate in patients with admission hypophosphatemia was not significantly different vs those with admission normophosphatemia (p=0.35).

[Figure 3 ILLUSTRATION OMITTED]

Nosocomial pneumonia is an important problem that contributes significantly to morbidity and mortality in hospitalized patients. Figure 4, which illustrates this problem, shows that 25 of 135 patients with hypophosphatemia and 10 of the 167 patients with normophosphatemia acquired their pneumonia during their hospital stay and this difference was statistically significant (p [is less than] 0.0001). Of the 25 patients who acquired their infection after admission to the hospital, 23 had normophosphatemia on admission and became hypophosphatemic 4 to 6 days prior to the infection episode. Thus, a significant proportion of patients seem to have acquired their hypophosphatemia in the hospital in association with the onset of bacterial pneumonia.

[Figure 4 ILLUSTRATION OMITTED]

DISCUSSION

The elderly ambulatory patient who comes to the emergency department with fever is very likely to have a serious pneumonia and in most instances will require hospitalization.[21] Even in young, healthy naval personnel, pneumonia has been found to be the major medical cause of lost workdays.[22] Although in western countries pneumonia has been replaced by more chronic pulmonary disorders as the chief cause of respiratory death, it still remains a very important cause of mortality in the United States.[2] Hospital-acquired pneumonia is typically much more serious than that acquired in the community,[23] in part because of impaired resistance. More importantly, organisms acquired in the hospital tend to be much more pathogenic. These complicated pneumonias are also more difficult to diagnose since the symptoms and signs of the underlying disease (like cardiac failure, malignancy, and acute respiratory distress syndrome) tend to mask the superimposed insult. Nosocomial bacterial infections of the respiratory tract occur in 0.5 to 5.0% of inpatients.[24] Although recent studies suggest that most patients who die with hospital-acquired pneumonia have a terminal condition on admission and the infection itself exerts little influence on the prognosis,[25,26] it is those patients who did not have a terminal condition on admission whose outcome may be significantly affected.[27] The association between nosocomial pneumonia and electrolyte disorders has been rarely studied in the literature.

In our study, we found that 18.5% of hypophosphatemic patients acquired their pneumonia after admission to the hospital compared with 6% of normophosphatemic patients. Moreover, of the 25 patients who developed pneumonia after admission to the hospital, 23 were normophosphatemic on admission and acquired the disorder 4 days before the onset of infection. This observation suggests a possible association between hypophosphatemia and the development of pneumonia and has implications on the management of admitted medical patients. Hypophosphatemia is well known to have adverse effects on many aspects of cell function. The diminished ability of granulocytes for phagocytosis and chemotaxis[5] in a low phosphorus milieu has been studied before. It is plausible that these patients were more prone for infection secondary to their hypophosphatemia. Moreover, the mortality rate among patients with hospital-acquired hypophosphatemia was significantly higher than those admitted with hypophosphatemia (in-hospital hypophosphatemia, 21 of 47 patients died vs admission hypophosphatemia, 22 of 88 patients died; p [is less than] 0.05). Although we did observe an association between the onset of hypophosphatemia and pneumonia, we did not study the effect of supplementation of phosphorus and its impact on the incidence of pneumonia. Hence, based on our data, we can only speculate on the cause and effect relationship between hypophosphatemia and the onset of respiratory infection.

We investigated the association between typical bacterial pneumonia and electrolyte abnormalities and tried to correlate the findings with the outcome in terms of survival and hospital stay. Although there have been studies looking at the association between hypophosphatemia and survival in surgical patients,23 in all hospitalized patients,[29,30] and in patients with respiratory illness,[31] to our knowledge, there are none in the literature looking at the association between bacterial respiratory infection and electrolyte disorders, especially in the setting of nosocomial pneumonia. The duration of in-hospital stay and the mortality rate were significantly increased in hypophosphatemic patients compared with normophosphatemic patients. Though these data are, in part, consistent with the data of Fisher et al,[31] there were considerable differences in the inclusion criteria used in the studies. Our sample size was much larger than that of Fisher et al,[31] with 302 patients with pneumonia compared to 73. Moreover, the Fisher group did not include diabetics and alcoholics in their hypophosphatemic cohort whereas these patients were included in their control group. Also, Fisher et al[31] did not exclude respiratory alkalosis or antacid consumption in their patient population. In their study, though the hospital stay was prolonged in the hypophosphatemic patients (24 [+ or -] 4 days vs 11.3 [+ or -] 10 days; p [is less than] 0.005) compared with their normophosphatemic counterparts, there was no difference in mortality between the two groups. In our study, in addition to increased mortality and prolonged hospital stay, we found that the hypophosphatemic subjects had associated electrolyte abnormalities like hypokalemia, hypoalbuminemia, and hypocalcemia.

Iezzoni et al,[32] in their recent retrospective cohort study, compared two clinical methods and three code-based methods to predict the probability of death in patients with all forms of bacterial pneumonia; they found that the clinical data-based methods predicted mortality more consistently than the code-based data. In this study involving 18,016 patients from 105 hospitals with a somewhat comparable age and sex distribution as in our study, serum sodium level of [is less than] 130 mEq/L, serum albumin level of [is less than] 2.4 g/dL, and arterial pH [is less than] 7.34 predicted increased mortality. Our study of patients with bacterial pneumonia followed up in a single hospital was different from Iezzoni et al[32] in that ours was a more homogeneous group. We did not specifically look at the predictors of mortality, though it is interesting that as in our study, a lower serum albumin level predicted mortality.

The combination of alkalosis, hypocalcemia, hypokalemia, and hypophosphatemia in patients admitted to the hospital with bacterial pneumonia signifies that these patients comprised a sicker group of patients. Even among patients with pneumonia, those with hypophosphatemia had a longer duration of hospitalization and higher mortality. Hypophosphatemia was especially ominous when it was acquired in-hospital, suggesting that these patients could have had underlying illnesses that could have contributed to their high risk of death.

CONCLUSION

We conclude that laboratory abnormalities, especially hypophosphatemia, may be a significant risk factor predicting the severity of the underlying illness in hospitalized patients with bacterial pneumonia.

REFERENCES

[1] Putnam JS, Tuazon CU. Symposium on infectious lung diseases: foreword. Med Clin North Am 1980; 64:317

[2] Bradsher RW Jr. Overwhelming pneumonia. Med Clin North Am 1983; 67:1233-50

[3] Haley RW, Schaberg DR, Crossley KB, et al. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 1981; 70:51-8

[4] Betro MG, Pain RW. Hypophosphatemia in a hospital population. BMJ 1972; 1:273-76

[5] Hodkinson HM. Serum inorganic phosphate in a geriatric in-patient population. Gerontol Clin 1973; 15:45-9

[6] Ryback RS, Eckardt MJ, Pantler CP. Clinical relationships between serum phosphorus and other blood chemistry values in alcoholics. Arch Intern Med 1980; 140:673-77

[7] Guillou PJ, Morgan DB, Hill GL. Hypophosphatemia: a complication of `innocuous dextrose-saline.' Lancet 1976; 2:710-12

[8] Juan D, Elrezak MA. Hypophosphatemia in hospitalized patients. JAMA 1979; 242:163-64

[9] Shoenfeld Y, Hager S, Berliner S, et al. Hypophosphatemia as diagnostic aid to sepsis: study of 141 patients. NY State J Med 1982; 82:163-65

[10] Knochel J. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977; 137:203-20

[11] Fitzgerald F. Clinical hypophosphatemia. Annu Rev Med 1978; 29:177-89

[12] Stoff JS. Phosphate homeostasis and hypophosphatemia. Am J Med 1982; 72:489-95

[13] Mohammed S, Knoll S, Van Amburg A, et al. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia. Am J Hematol 1994; 46:369-70

[14] Crook MA. Hypophosphatemia and hypokalemia in patients with hypomagnesemia. Br J Biomed Sci 1994; 51:24-7

[15] Brown GR, Greenwood JK. Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill. Ann Pharmacother 1994; 28:626-32

[16] Johnson DH, Cunha BA. Atypical pneumonia: clinical and extrapulmonary features of Chlamydia, Mycoplasma, and Legionella infections. Postgrad Med 1993; 93:69-82

[17] Rapoport S, Stevens CD, Engel GL, et al. The effect of voluntary overbreathing on the electrolyte equilibrium of arterial blood in man. J Biol Chem 1946; 163:411-27

[18] Salzman HA, Heyman A, Sieker HO. Correlation of clinical and physiologic manifestations of sustained hyperventilation. N Engl J Med 1963; 268:1431-36

[19] George WK, George WD, Smith JP, et al. Changes in serum calcium, serum phosphate and red-cell phosphate during hyperventilation. N Engl J Med 1964; 270:726-28

[20] Craddock PR, Yawata Y, VanSanten L, et al. Acquired phagocyte dysfunction: a complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med 1974; 290:1403-07

[21] Keating HG III, Klimex JJ, Levine DS, et al. Effect of aging on the clinical significance of fever in ambulatory adult patients. J Am Geriatr Soc 1984; 32:282-87

[22] Pazzaglia G, Pasternack M. Pneumonia morbidity in United States naval personnel during 1970-1979. J Infect Dis 1982; 145:766

[23] Eickhoff TC. Nosocomial infections. N Engl J Med 1982; 306: 1545-46

[24] Cross AS, Roup B. Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981; 70:681-85

[25] Gross PA, van Antwerpen C. Nosocomial infections and hospital deaths: a case-control study. Am J Med 1983; 75:658-62

[26] Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia: analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984; 129:668-71

[27] Stevens GP, Jacobson JA, Burke JP. Changing patterns of hospital infections and antibiotic use: prevalence surveys in a community hospital. Arch Intern Med 1981; 141:587-92

[28] Swaminathan R, Bradley P, Morgan DB, et al. Hypophosphatemia in surgical patients. Surg Gynecol Obstet 1979; 148:448-54

[29] Halevy J, Bulvik S. Severe hypophosphatemia in hospitalized patients. Arch Intern Med 1988; 148:153-55

[30] Camp MA, Allon M. Severe hypophosphatemia in hospitalized patients. Miner Electrolyte Metab 1990; 16:365-68

[31] Fisher J, Magid N, Kallman C, et al. Respiratory illness and hypophosphatemia. Chest 1983; 83:504-08

[32] Iezzoni LI, Shwartz M, Ash AS, et al. Using severity measures to predict the likelihood of death from pneumonia inpatients. J Gen Intern Med 1996; 11:23-31

(*) From the Department of Medicine (Drs. Sankaran Mattana, Ahuja, Patel, and Singhal, and Ms. Bhat), Long Island Jewish Medical Center, Long Island Campus for Albert Einstein College of Medicine, Bronx, NY; and the Department of Decision Sciences (Mr. Pollack), St. John's University, Jamaica, NY.

Manuscript received April 8, 1996; revision accepted August 24.

Reprint requests: Dr. Singhal, Division of Nephrology, Room 228, Long Island Jewish Medical Center, New Hyde Park, NY 11040

COPYRIGHT 1997 American College of Chest Physicians
COPYRIGHT 2004 Gale Group

Return to Cholesterol pneumonia
Home Contact Resources Exchange Links ebay